AlzeCure Publishes its Interim Report for January – March 2023
STOCKHOLM, SE / ACCESSWIRE / May 04, 2023 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January - March 2023 is now available on the company's website: …
Weiterlesen »